PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

Recruiting Phase 3 Interventional Study
Traumatic Brain Injury
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
1,100 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria The pragmatic nature of this study seeks to include all consecutive patients presenting with significant TBI, regardless of whether ICB is evident at presentation. Inclusion criteria are the following: i) Patients with severe TBI defined as GCS of ≤8, or ii) Patients with moder…
Contacts

Farhad Pirouzmand, MD, MSc, FRCSC

416-480-6100

farhad.pirouzmand@sunnybrook.ca

CONTACT

Kanthi Kavikondala, CCRP

416-480-6100

protest@sunnybrook.ca

CONTACT